The global LFIA based rapid test market was valued at $4,725 million in 2018, and is projected to reach $8,494 million by 2026, registering a CAGR of 7.6% from 2019 to 2026.
Lateral flow tests, or lateral flow immunochromatographic assays, are simple cellulose-based medical devices used to detect the presence of a target analyte in sample without use of specialized equipment where preliminary screening tests need to be conducted. These tests are incorporated in diagnosis of different diseases and health conditions such as HIV, influenza, malaria, pregnancy & fertility, drug screening, and others.
It is estimated that LFIA based rapid test market is expected to experience significant market growth during the forecast period as these tests are easy to perform, quick, and provide specific results; hence, are used in settings with limited resources. In addition, increased promotional activities by manufacturers encourage the usage these tests, which further facilitate the growth of the market. However, stringent government regulations for the approval of rapid tests and recall of several products due to false results are expected to impede the market growth.
Moreover, increase in awareness regarding early diagnosis of disease, surge in initiatives by the government agencies, increase in incidence of infectious diseases, and need for low cost as well as accurate diagnostic testing are further supports the market growth.
The global rapid tests market is segmented into application, technique, end user, and region. The applications covered in the study include, infectious disease, pregnancy & fertility, toxicology, and others. Depending on techniques, the market is classified into competitive assay, sandwich assay, and multiplex detection assay. The infectious disease segment is further influenza, mosquito-borne diseases, HIV, hepatitis, and others. In addition, Dengue, chikungunya, malaria, and others are covered under mosquito-borne diseases. According to end user, the market is segmented as hospital & clinic, diagnostic laboratory, home care, and others.
By region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, Philippines, Vietnam, Malaysia, Thailand, Singapore, Indonesia, Myanmar, Sri Lanka, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Application
• Infectious disease
o Influenza
o Mosquito-borne diseases
§ Dengue
§ Chikungunya
§ Malaria
§ Others
o HIV
o Hepatitis
o Others
• Pregnancy & fertility
• Toxicology
• Others
By Technique type
• Competitive assay
• Sandwich assay
• Multiplex detection assay
By End User
• Hospital & clinic
• Diagnostic laboratory
• Home care
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Philippines
o Vietnam
o Malaysia
o Thailand
o Singapore
o Indonesia
o Myanmar
o Sri Lanka
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
o
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Abbott Laboratories (Alere Inc.)
• Becton, Dickinson and Company
• Bio-rad Laboratories, Inc.
• Danaher Corporation (Cepheid, Inc.)
• Hologic, Inc.
• Quidel Corporation
• F. Hoffmann-La Roche AG (Roche Diagnostics)
• BIOMERIEUX SA
• QIAGEN N.V.
• Thermo Fisher Scientific
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• Abingdon Health
• ARKRAY, Inc.
• Biocom Diagnostics
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List Of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings Of The Study
2.1.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Market Player Positioning, 2018
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Benefits Of Lfia Based Rapid Tests Over Laboratory Testing
3.3.1.2. Increase In Initiatives Of Government And Nonprofit Organizations Towards Health Awareness
3.3.1.3. Increase In Healthcare Expenditure Worldwide
3.3.2. Restraint
3.3.2.1. Inadequate Reimbursement Policies For Lfia Based Rapid Test Diagnostics
3.3.3. Opportunities
3.3.3.1. Growth Opportunities In The Emerging Markets
3.3.3.2. Increase In Prevalence Of Various Chronic And Infectious Diseases Across The World
3.3.4. Impact Analysis
Chapter 4: Lfia Based Rapid Test Market, By Application
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Infectious Disease
4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Type
4.2.2.1. Influenza
4.2.2.2. Mosquito-Borne
4.2.2.2.1. Mosquito-Borne Diseases Market Size And Forecast, By Type
4.2.2.2.2. Dengue
4.2.2.2.2.1. Dengue Diseases Market Size
4.2.2.2.3. Chikungunya
4.2.2.2.3.1. Chikungunya Diseases Market Size
4.2.2.2.4. Malaria
4.2.2.2.4.1. Malaria Diseases Market Size
4.2.2.2.5. Others
4.2.2.2.5.1. Others Diseases Market Size
4.2.2.3. Hiv
4.2.2.4. Hepatitis
4.2.2.5. Others
4.2.3. Market Size And Forecast, By Region
4.2.4. Market Analysis, By Country
4.3. Pregnancy & Fertility
4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Toxicology
4.4.1. Key Market Trends, Growth Factors, And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
4.5. Others
4.5.1. Key Market Trends, Growth Factors, And Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis, By Country
Chapter 5: Lfia Based Rapid Test Market, By Technique Type
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Competitive Assay Lfia Based Rapid Test
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country
5.3. Sandwich Assay Lfia Based Rapid Test
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country
5.4. Multiplex Detection Assay Lfia Based Rapid Test
5.4.1. Arket Size And Forecast, By Region
5.4.2. Market Analysis, By Country
Chapter 6: Lfia Based Rapid Test Market, By End User
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Hospital & Clinic
6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country
6.3. Diagnostic Laboratory
6.3.1. Market Size And Forecast
6.3.2. Market Analysis, By Country
6.4. Home Care
6.4.1. Market Size And Forecast
6.4.2. Market Analysis, By Country
6.5. Others
6.5.1. Market Size And Forecast
6.5.2. Market Analysis, By Country
Chapter 7: Lfia Based Rapid Test Market By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Lfia Based Rapid Test Market, By Application
7.2.2.1.2. U.S. Lfia Based Rapid Test Market, By Technique Type
7.2.2.1.3. U.S. Lfia Based Rapid Test Market, By End User
7.2.2.2. Canada
7.2.2.2.1. Canada Lfia Based Rapid Test Market, By Application
7.2.2.2.2. Canada Lfia Based Rapid Test Market, By Technique Type
7.2.2.2.3. Canada Lfia Based Rapid Test Market, By End User
7.2.2.3. Mexico
7.2.2.3.1. Mexico Lfia Based Rapid Test Market, By Application
7.2.2.3.2. Mexico Lfia Based Rapid Test Market, By Technique Type
7.2.2.3.3. Mexico Lfia Based Rapid Test Market, By End User
7.2.3. North America Lfia Based Rapid Test Market, By Application
7.2.4. North America Lfia Based Rapid Test Market, By Technique Type
7.2.5. North America Lfia Based Rapid Test Market, By End User
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.2.1. Germany
7.3.2.1.1. Germany Lfia Based Rapid Test Market, By Application
7.3.2.1.2. Germany Lfia Based Rapid Test Market, By Technique Type
7.3.2.1.3. Germany Lfia Based Rapid Test Market, By End User
7.3.2.2. France
7.3.2.2.1. France Lfia Based Rapid Test Market, By Application
7.3.2.2.2. France Lfia Based Rapid Test Market, By Technique Type
7.3.2.2.3. France Lfia Based Rapid Test Market, By End User
7.3.2.3. Uk
7.3.2.3.1. Uk Lfia Based Rapid Test Market, By Application
7.3.2.3.2. Uk Lfia Based Rapid Test Market, By Technique Type
7.3.2.3.3. Uk Lfia Based Rapid Test Market, By End User
7.3.2.4. Italy
7.3.2.4.1. Italy Lfia Based Rapid Test Market, By Application
7.3.2.4.2. Italy Lfia Based Rapid Test Market, By Technique Type
7.3.2.4.3. Italy Lfia Based Rapid Test Market, By End User
7.3.2.5. Spain
7.3.2.5.1. Spain Lfia Based Rapid Test Market, By Application
7.3.2.5.2. Spain Lfia Based Rapid Test Market, By Technique Type
7.3.2.5.3. Spain Lfia Based Rapid Test Market, By End User
7.3.2.6. Rest Of Europe
7.3.2.6.1. Rest Of Europe Lfia Based Rapid Test Market, By Application
7.3.2.6.2. Rest Of Europe Lfia Based Rapid Test Market, By Technique Type
7.3.2.6.3. Rest Of Europe Lfia Based Rapid Test Market, By End User
7.3.3. Europe Lfia Based Rapid Test Market, By Application
7.3.4. Europe Lfia Based Rapid Test Market, By Technique Type
7.3.5. Europe Lfia Based Rapid Test Market, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.2.1. Japan
7.4.2.1.1. Japan Lfia Based Rapid Test Market, By Application
7.4.2.1.2. Japan Lfia Based Rapid Test Market, By Technique Type
7.4.2.1.3. Japan Lfia Based Rapid Test Market, By End User
7.4.2.2. China
7.4.2.2.1. China Lfia Based Rapid Test Market, By Application
7.4.2.2.2. China Lfia Based Rapid Test Market, By Technique Type
7.4.2.2.3. China Lfia Based Rapid Test Market, By End User
7.4.2.3. Australia
7.4.2.3.1. Australia Lfia Based Rapid Test Market, By Application
7.4.2.3.2. Australia Lfia Based Rapid Test Market, By Technique Type
7.4.2.3.3. Australia Lfia Based Rapid Test Market, By End User
7.4.2.4. India
7.4.2.4.1. India Lfia Based Rapid Test Market, By Application
7.4.2.4.2. India Lfia Based Rapid Test Market, By Technique Type
7.4.2.4.3. India Lfia Based Rapid Test Market, By End User
7.4.2.5. Philippines
7.4.2.5.1. Philippines Lfia Based Rapid Test Market, By Application
7.4.2.5.2. Philippines Lfia Based Rapid Test Market, By Technique Type
7.4.2.5.3. Philippines Lfia Based Rapid Test Market, By End User
7.4.2.6. Vietnam
7.4.2.6.1. Vietnam Lfia Based Rapid Test Market, By Application
7.4.2.6.2. Vietnam Lfia Based Rapid Test Market, By Technique Type
7.4.2.6.3. Vietnam Lfia Based Rapid Test Market, By End User
7.4.2.7. Malaysia
7.4.2.7.1. Malaysia Lfia Based Rapid Test Market, By Application
7.4.2.7.2. Malaysia Lfia Based Rapid Test Market, By Technique Type
7.4.2.7.3. Malaysia Lfia Based Rapid Test Market, By End User
7.4.2.8. Thailand
7.4.2.8.1. Thailand Lfia Based Rapid Test Market, By Application
7.4.2.8.2. Thailand Lfia Based Rapid Test Market, By Technique Type
7.4.2.8.3. Thailand Lfia Based Rapid Test Market, By End User
7.4.2.9. Singapore
7.4.2.9.1. Singapore Lfia Based Rapid Test Market, By Application
7.4.2.9.2. Singapore Lfia Based Rapid Test Market, By Technique Type
7.4.2.9.3. Singapore Lfia Based Rapid Test Market, By End User
7.4.2.10. Indonesia
7.4.2.10.1. Indonesia Lfia Based Rapid Test Market, By Application
7.4.2.10.2. Indonesia Lfia Based Rapid Test Market, By Technique Type
7.4.2.10.3. Indonesia Lfia Based Rapid Test Market, By End User
7.4.2.11. Myanmar
7.4.2.11.1. Myanmar Lfia Based Rapid Test Market, By Application
7.4.2.11.2. Myanmar Lfia Based Rapid Test Market, By Technique Type
7.4.2.11.3. Myanmar Lfia Based Rapid Test Market, By End User
7.4.2.12. Sri Lanka
7.4.2.12.1. Sri Lanka Lfia Based Rapid Test Market, By Application
7.4.2.12.2. Sri Lanka Lfia Based Rapid Test Market, By Technique Type
7.4.2.12.3. Sri Lanka Lfia Based Rapid Test Market, By End User
7.4.2.13. Rest Of Asia-Pacific
7.4.2.13.1. Rest Of Asia-Pacific Lfia Based Rapid Test Market, By Application
7.4.2.13.2. Rest Of Asia-Pacific Lfia Based Rapid Test Market, By Technique Type
7.4.2.13.3. Rest Of Asia-Pacific Lfia Based Rapid Test Market, By End User
7.4.3. Asia-Pacific Lfia Based Rapid Test Market, By Application
7.4.4. Asia-Pacific Lfia Based Rapid Test Market, By Technique Type
7.4.5. Asia-Pacific Lfia Based Rapid Test Market, By End User
7.5. Lamea
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.2.1. Brazil
7.5.2.1.1. Japan Lfia Based Rapid Test Market, By Application
7.5.2.1.2. Brazil Lfia Based Rapid Test Market, By Technique Type
7.5.2.1.3. Brazil Lfia Based Rapid Test Market, By End User
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia Lfia Based Rapid Test Market, By Application
7.5.2.2.2. Saudi Arabia Lfia Based Rapid Test Market, By Technique Type
7.5.2.2.3. Saudi Arabia Lfia Based Rapid Test Market, By End User
7.5.2.3. South Africa
7.5.2.3.1. South Africa Lfia Based Rapid Test Market, By Application
7.5.2.3.2. South Africa Lfia Based Rapid Test Market, By Technique Type
7.5.2.3.3. South Africa Lfia Based Rapid Test Market, By End User
7.5.2.4. Rest Of Lamea
7.5.2.4.1. Rest Of Lamea Lfia Based Rapid Test Market, By Application
7.5.2.4.2. Rest Of Lamea Lfia Based Rapid Test Market, By Technique Type
7.5.2.4.3. Rest Of Lamea Lfia Based Rapid Test Market, By End User
7.5.3. Lamea Lfia Based Rapid Test Market, By Application
7.5.4. Lamea Lfia Based Rapid Test Market, By Technique Type
7.5.5. Lamea Lfia Based Rapid Test Market, By End User
Chapter 8: Competitive Landscape
8.1. Introduction
8.2. Competitive Dashboard
8.3. Competitive Heatmap
Chapter 9: Company Profiles
9.1. Abbott Laboratories (Alere Inc.)
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Business Performance
9.1.6. Key Strategic Moves And Developments
9.2. Becton Dickinson And Company
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.2.5. Business Performance
9.3. Biomerieux Sa
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio
9.3.5. Business Performance
9.4. Bio-Rad Laboratories, Inc.
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.4.5. Business Performance
9.5. Danaher Corporation (Cepheid, Inc.)
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.5.5. Business Performance
9.5.6. Key Strategic Moves And Developments
9.6. F. Hoffmann-La Roche Ag (Roche Diagnostics)
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.6.5. Business Performance
9.7. Hologic, Inc.
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio
9.8. Qiagen N.V.
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.8.5. Business Performance
9.9. Quidel Corporation
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Product Portfolio
9.9.5. Business Performance
9.10. Thermo Fisher Scientific
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Product Portfolio
9.10.5. Business Performance
Trends Market Research © Copyright 2020. All Rights Reserved.
